Phase 2Recruiting
Endocannabinoids in Reward
The Contribution of the Endocannabinoid System to Sex Differences in THC-associated Reward
- Sponsor
- Medical University of South Carolina (Academic or other)
- Enrollment
- 78 planned
- Conditions
- Cannabis Use Disorder
- Interventions
- Dronabinol; Placebo
- Ages
- adults
- Registry
- NCT07815691
Full record on ClinicalTrials.gov
From the registry
This study will examine sex differences in the effects of cannabis in people that regularly use it. Men and women that use cannabis at least 4 days a week will participate in a study involving 3 in-person visits. The first visit will be used to determine eligibility for the study. The other two visits will last 7 hours each and take place at least two days apart. Visits include administration of either THC, the chemical responsible for many of the psychoactive effects of cannabis, or a placebo; completion of questionnaires; and a 1-hour brain scan. One visit will also include a blood draw for genetic testing.
Primary outcomes
- Nucleus accumbens glutamate
- Drug Effects Questionnaire (DEQ) - Like Drug Effect
- Sex differences in genetics
History
Primary completion expected
Last registry update
Started
Registered